Reduced sleep efficiency, measured using an objective device, was related to an increased prevalence of home hypertension in Japanese adults.


Journal

Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690

Informations de publication

Date de publication:
01 2020
Historique:
received: 05 05 2019
accepted: 21 08 2019
revised: 27 07 2019
pubmed: 20 9 2019
medline: 17 4 2021
entrez: 20 9 2019
Statut: ppublish

Résumé

Few studies have reported the relationship between reduced sleep efficiency and the prevalence of hypertension independent of sleep duration in Japan. This study aimed to evaluate whether reduced sleep efficiency, measured using an objective device for >1 week, was related to an increased prevalence of hypertension independent of sleep duration in the general Japanese population. We conducted a cross-sectional study of 904 participants aged ≥20 years who lived in Miyagi Prefecture, Japan. Sleep efficiency was measured using a contactless biomotion sleep sensor for 10 continuous days. The participants were classified into two groups according to their sleep efficiency: reduced (<90%) or not reduced (≥90%). Hypertension was defined as morning home blood pressure ≥135/85 mmHg or self-reported treatment for hypertension. Multivariable logistic regression models were used to obtain odds ratios (ORs) and 95% confidence intervals (CIs) to assess the relationship between sleep efficiency and hypertension adjusted for potential confounders. The results showed that two hundred and ninety-four individuals (32.5%) had reduced sleep efficiency, and 331 (36.6%) had hypertension. Individuals with reduced sleep efficiency had a higher body mass index and shorter sleep duration. In the multivariable analysis, reduced sleep efficiency was significantly related to an increased prevalence of hypertension (OR, 1.62; 95% CI, 1.15-2.28). In conclusion, reduced sleep efficiency was significantly related to an increased prevalence of hypertension in Japanese adults. Improvements in sleep efficiency may be important to reduce blood pressure in Japanese adults.

Identifiants

pubmed: 31534189
doi: 10.1038/s41440-019-0329-0
pii: 10.1038/s41440-019-0329-0
pmc: PMC8076010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-29

Références

Hypertension. 2010 Jun;55(6):1346-51
pubmed: 20385970
Am J Hypertens. 2010 Feb;23(2):174-9
pubmed: 19927130
Am J Hypertens. 1999 Jan;12(1 Pt 1):63-8
pubmed: 10075386
J Hypertens. 2018 Mar;36(3):601-607
pubmed: 28957850
Hypertens Res. 2019 Feb;42(2):195-203
pubmed: 30504820
Hypertension. 2006 May;47(5):833-9
pubmed: 16585410
Sleep Breath. 2015 Mar;19(1):91-8
pubmed: 24614968
J Sleep Res. 2011 Jun;20(2):356-66
pubmed: 20704645
Sleep. 2010 Jan;33(1):89-95
pubmed: 20120625
Sensors (Basel). 2015 Aug 03;15(8):18950-64
pubmed: 26247948
Hypertens Res. 2012 Oct;35(10):1012-8
pubmed: 22763475
Chest. 2018 Jan;153(1):87-93
pubmed: 28970105
J Clin Sleep Med. 2013 Jun 15;9(6):553-7
pubmed: 23772188
J Am Soc Hypertens. 2017 Feb;11(2):122-129
pubmed: 28109722
Hypertens Res. 2018 Sep;41(9):669-678
pubmed: 29789641
Sleep. 2006 Aug;29(8):1009-14
pubmed: 16944668
J Appl Physiol (1985). 2012 Jul;113(2):232-6
pubmed: 22539169
Sleep Med Rev. 2014 Dec;18(6):509-19
pubmed: 24846771
Epidemiology. 2008 Nov;19(6):838-45
pubmed: 18854708
J Epidemiol. 2012;22(5):462-8
pubmed: 22850546
Hypertension. 1996 Jun;27(6):1318-24
pubmed: 8641742
Sleep. 2004 Sep 15;27(6):1097-103
pubmed: 15532203
J Hypertens. 2012 Jul;30(7):1289-99
pubmed: 22499289
Hypertens Res. 2018 Nov;41(11):957-964
pubmed: 30206322
PLoS One. 2016 May 11;11(5):e0155116
pubmed: 27166822
Am J Hypertens. 2016 Dec 1;29(12):1353-1357
pubmed: 27538722

Auteurs

Takumi Hirata (T)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. t-hirata@megabank.tohoku.ac.jp.
Graduate School of Medicine, Tohoku University, Sendai, Japan. t-hirata@megabank.tohoku.ac.jp.

Tomohiro Nakamura (T)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Mana Kogure (M)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Naho Tsuchiya (N)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Akira Narita (A)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Ken Miyagawa (K)

OMRON Healthcare Co., Ltd., Muko, Japan.

Kotaro Nochioka (K)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University Hospital, Tohoku University, Sendai, Japan.

Akira Uruno (A)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Taku Obara (T)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University Hospital, Tohoku University, Sendai, Japan.

Naoki Nakaya (N)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Hirohito Metoki (H)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
School of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Masahiro Kikuya (M)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Teikyo University School of Medicine, Tokyo, Japan.

Junichi Sugawara (J)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University Hospital, Tohoku University, Sendai, Japan.

Shinichi Kuriyama (S)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.
International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Ichiro Tsuji (I)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Shigeo Kure (S)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University Hospital, Tohoku University, Sendai, Japan.

Atsushi Hozawa (A)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Graduate School of Medicine, Tohoku University, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH